NeuroNexus is a global leader for innovative neural interface products and technologies to meet both current and upcoming needs in neuroscience research, neurosurgery, and neuromodulation.
NeuroNexus powers neuroscience research through innovative neural probes, systems, and data analytics software. NeuroNexus probes include a full line of high-quality, customizable microelectrode arrays for electrophysiology and optogenetics research. NeuroNexus systems provide integrated plug-and-play solutions to support diverse neurophysiology experiments and workflows. The NeuroNexus data analytics software platform provides powerful, scalable, cross-platform analytical and visualization tools for managing and analyzing neurophysiological data -- from individual experiments to complex multi-investigator 'big data'.
DataMind makes DataMind OS, the Intelligent Data OS: the whole data and AI stack in one product, installed on your own servers in about 20 minutes. DataMind is based in Tbilisi, Georgia, and works with organizations in banking, insurance, retail, telecom, energy and more.
DataMind OS replaces the stack of separate tools most companies buy, run and connect. It brings 29 apps under one login: connectors for any source (built-in, any API, or written by AI), a data lake and warehouse, ETL/ELT and workflows, lineage, a SQL editor, DataPrism BI, Slides, and AI Minds that answer plain-language questions on your own data.
Your data stays on your servers. AI calls go only to zero-data-retention model endpoints, personal data reaches models as tokens, and access rules for objects, columns and rows are enforced in the database.
One plan covers the whole company, with unlimited users. Try the full OS free for two months on your own servers, no card.
Faster, data-informed decisions, without a stack of tools to run.
Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. The company plans to revolutionize the field of cataract surgery by offering the Synchrony® dual optic accommodating IOL. This long-awaited, 3-dimensional device represents a major breakthrough in ophthalmic technology—an IOL that is designed to allow patients to have a continuous range of focus without the use of spectacles or the optical disadvantages of monovision or multifocal implants.